In the present study, we provided new insight into LCN2 as a potential biomarker for the prediction of CAC, and demonstrated that LCN2 is a key regulator of cell survival and tumor development mediated by STAT3/NF-kB activation. Here, NFKB1 is linked to neoplasm.